Skip to main content
OpenTrials

Clinical trial condition

Peripheral T Cell Lymphoma

Explore clinical trials studying Peripheral T Cell Lymphoma. Study availability and eligibility vary by location and protocol.

52 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Peripheral T Cell Lymphoma trial results

Completed

Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides

NCT04101331

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center) Birmingham, Alabama, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Los Angeles (UCLA) Health Los Angeles, California, United States
  • Emory University Clinic/Winship Cancer Institute Atlanta, Georgia, United States
View all 69 locations
View Trial Details
Completed

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms

NCT03493451

Conditions
ALK-Positive Anaplastic Large Cell Lymphoma, ALK-negative Anaplastic Large Cell Lymphoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +36 more
Locations
  • British Columbia Cancer Agency the Vancouver Centre Vancouver, British Columbia, Canada
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Beijing Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 24 locations
View Trial Details
Completed

A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)

NCT01716806

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of South Alabama - Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Urological Institute Anchorage, Alaska, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
View all 54 locations
View Trial Details
Completed

Minimal Residual Disease in Peripheral T-cell Lymphoma

NCT03297697

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Safety and Efficacy of Lacutamab in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma That Express KIR3DL2

NCT05321147

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of Alabama at Birmingham- O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of California at Irvine - Chao Family Comprehensive Cancer Center Orange, California, United States
  • Goshen Health- Goshen Hospital Goshen, Indiana, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
View all 20 locations
View Trial Details
Completed

Evaluation of the Combination of Romidepsin and Carfilzomib in Relapsed/Refractory Peripheral T Cell Lymphoma Patients

NCT03141203

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • St James's University Hospital Leeds, United Kingdom
  • Leicester Royal Infirmary Leicester, United Kingdom
  • Clatterbridge Cancer Centre Liverpool, United Kingdom
View all 13 locations
View Trial Details
Completed

Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma

NCT00007345

Conditions
Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • University of Arkansas Little Rock, Arkansas, United States
  • City of Hope National Cancer Center Duarte, California, United States
  • Mercy General Hospital Sacramento, California, United States
View all 13 locations
View Trial Details

Related conditions